Testing effectiveness (Phase 2)Study completedNCT00109590
What this trial is testing
Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 175